Corrigendum: Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma

Bibliographic Details
Main Authors: Hanwen Lu, Liwei Zhou, Bingchang Zhang, Yuanyuan Xie, Huiyin Yang, Zhanxiang Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1244638/full
_version_ 1797783776947863552
author Hanwen Lu
Hanwen Lu
Liwei Zhou
Liwei Zhou
Bingchang Zhang
Bingchang Zhang
Yuanyuan Xie
Yuanyuan Xie
Huiyin Yang
Huiyin Yang
Zhanxiang Wang
Zhanxiang Wang
Zhanxiang Wang
author_facet Hanwen Lu
Hanwen Lu
Liwei Zhou
Liwei Zhou
Bingchang Zhang
Bingchang Zhang
Yuanyuan Xie
Yuanyuan Xie
Huiyin Yang
Huiyin Yang
Zhanxiang Wang
Zhanxiang Wang
Zhanxiang Wang
author_sort Hanwen Lu
collection DOAJ
first_indexed 2024-03-13T00:30:40Z
format Article
id doaj.art-2363d992cdaa4e6bab51972c4aed64c2
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-03-13T00:30:40Z
publishDate 2023-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-2363d992cdaa4e6bab51972c4aed64c22023-07-10T13:23:27ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2023-07-011010.3389/fmed.2023.12446381244638Corrigendum: Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in gliomaHanwen Lu0Hanwen Lu1Liwei Zhou2Liwei Zhou3Bingchang Zhang4Bingchang Zhang5Yuanyuan Xie6Yuanyuan Xie7Huiyin Yang8Huiyin Yang9Zhanxiang Wang10Zhanxiang Wang11Zhanxiang Wang12Department of Neurosurgery, Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, ChinaDepartment of Neuroscience, Institute of Neurosurgery, School of Medicine, Xiamen University, Xiamen, ChinaDepartment of Neurosurgery, Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, ChinaDepartment of Neurosurgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, ChinaDepartment of Neurosurgery, Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, ChinaDepartment of Neurosurgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, ChinaDepartment of Neurosurgery, Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, ChinaDepartment of Neurosurgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, ChinaDepartment of Neurosurgery, Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, ChinaDepartment of Neuroscience, Institute of Neurosurgery, School of Medicine, Xiamen University, Xiamen, ChinaDepartment of Neurosurgery, Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, ChinaDepartment of Neuroscience, Institute of Neurosurgery, School of Medicine, Xiamen University, Xiamen, ChinaDepartment of Neurosurgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Chinahttps://www.frontiersin.org/articles/10.3389/fmed.2023.1244638/fullCuproptosisgliomaprognostic biomarkerimmune infiltrationlipoylation
spellingShingle Hanwen Lu
Hanwen Lu
Liwei Zhou
Liwei Zhou
Bingchang Zhang
Bingchang Zhang
Yuanyuan Xie
Yuanyuan Xie
Huiyin Yang
Huiyin Yang
Zhanxiang Wang
Zhanxiang Wang
Zhanxiang Wang
Corrigendum: Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma
Frontiers in Medicine
Cuproptosis
glioma
prognostic biomarker
immune infiltration
lipoylation
title Corrigendum: Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma
title_full Corrigendum: Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma
title_fullStr Corrigendum: Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma
title_full_unstemmed Corrigendum: Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma
title_short Corrigendum: Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma
title_sort corrigendum cuproptosis key gene fdx1 is a prognostic biomarker and associated with immune infiltration in glioma
topic Cuproptosis
glioma
prognostic biomarker
immune infiltration
lipoylation
url https://www.frontiersin.org/articles/10.3389/fmed.2023.1244638/full
work_keys_str_mv AT hanwenlu corrigendumcuproptosiskeygenefdx1isaprognosticbiomarkerandassociatedwithimmuneinfiltrationinglioma
AT hanwenlu corrigendumcuproptosiskeygenefdx1isaprognosticbiomarkerandassociatedwithimmuneinfiltrationinglioma
AT liweizhou corrigendumcuproptosiskeygenefdx1isaprognosticbiomarkerandassociatedwithimmuneinfiltrationinglioma
AT liweizhou corrigendumcuproptosiskeygenefdx1isaprognosticbiomarkerandassociatedwithimmuneinfiltrationinglioma
AT bingchangzhang corrigendumcuproptosiskeygenefdx1isaprognosticbiomarkerandassociatedwithimmuneinfiltrationinglioma
AT bingchangzhang corrigendumcuproptosiskeygenefdx1isaprognosticbiomarkerandassociatedwithimmuneinfiltrationinglioma
AT yuanyuanxie corrigendumcuproptosiskeygenefdx1isaprognosticbiomarkerandassociatedwithimmuneinfiltrationinglioma
AT yuanyuanxie corrigendumcuproptosiskeygenefdx1isaprognosticbiomarkerandassociatedwithimmuneinfiltrationinglioma
AT huiyinyang corrigendumcuproptosiskeygenefdx1isaprognosticbiomarkerandassociatedwithimmuneinfiltrationinglioma
AT huiyinyang corrigendumcuproptosiskeygenefdx1isaprognosticbiomarkerandassociatedwithimmuneinfiltrationinglioma
AT zhanxiangwang corrigendumcuproptosiskeygenefdx1isaprognosticbiomarkerandassociatedwithimmuneinfiltrationinglioma
AT zhanxiangwang corrigendumcuproptosiskeygenefdx1isaprognosticbiomarkerandassociatedwithimmuneinfiltrationinglioma
AT zhanxiangwang corrigendumcuproptosiskeygenefdx1isaprognosticbiomarkerandassociatedwithimmuneinfiltrationinglioma